Ultragenyx Pharmaceutical

Aktienkurs
24.70
Täglich Wechseln
0.91 3.83%
Monatlich
2.07%
Jährlich
-45.53%
Q1 Prognose
23.94




Ebitda Veränderung Datum
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Agios Pharmaceuticals USD -125.8M 20.45M 2025-06
Alnylam Pharmaceuticals USD 381.78M 362.95M 2025-09
BioMarin Pharmaceutical USD 295.45M 49.49M 2025-06
Insmed USD -297.13M 71.11M 2025-06
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Kyowa Hakko Kirin JPY 32.28B 13.25B 2025-09
MacroGenics USD 21.95M 55.39M 2025-09
Moderna USD -208M 552M 2025-09
Neurocrine Biosciences USD 246.7M 93.8M 2025-09
PTC Therapeutics USD -33.11M 1B 2025-06
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Sarepta Therapeutics USD 126.42M 416.82M 2025-06
Ultragenyx Pharmaceutical USD -91.34M 35.09M 2025-06
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09


Ultragenyx Pharmaceutical - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.